110351-92-3 (20R-喜树碱,(R)-(-)-Camptothecin)

右旋喜树碱;20R-喜树碱;

1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,4-ethyl-4-hydroxy-, (4R)-;20R-Camptothecin;(R)-(-)-Camptothecin;(4R)-4-ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione;(R)-(-)-Camptothecine;(R)-4-Ethyl-4-hydroxy-1H-pyrano[3’,4’:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione;(R)-Camptothecin;(4R)-4β-Ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione;TNP00113;crlx101;(20R)-Camptothecin;BDBM50406992;(alphaR)-alpha-Ethyl-alpha-hydroxy-8-(hydr;CS-0164099;CCG-36183;NCGC00017231-02;NCGC00142465-01;110351-92-3;NCGC00017231-01;CHEMBL71836;(19R)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione;(R)-4-ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione? (Irinotecan Impurity pound(c);DTXSID80149224;SCHEMBL4304557;(S)-4-Ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14-(4H,12H)-dione;G87986;(R)-4-Ethyl-4-hydroxy-1,12-dihydro-14H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H)-dione;

VSJKWCGYPAHWDS-HXUWFJFHSA-N

1S/C20H16N2O4/c1-2-20(25)14-8-16-17-12(7-11-5-3-4-6-15(11)21-17)9-22(16)18(23)13(14)10-26-19(20)24/h3-8,25H,2,9-10H2,1H3/t20-/m1/s1

O1C([C@@](CC)(C2C=C3C4C(=CC5C=CC=CC=5N=4)CN3C(C=2C1)=O)O)=O